Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine

Roger Chou; Jane Ballantyne; Anna Lembke

doi:10.7326/M19-1488

Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine

Roger Chou, Jane Ballantyne, Anna Lembke

Medical Informatics and Clinical Epidemiology

Research output: Contribution to journal › Comment/debate › peer-review

29 Scopus citations

Original language	English (US)
Pages (from-to)	427-429
Number of pages	3
Journal	Annals of internal medicine
Volume	171
Issue number	6
DOIs	https://doi.org/10.7326/M19-1488
State	Published - Sep 17 2019

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/M19-1488

Cite this

@article{0abbc59c84ad44dea80266caad7bba18,

title = "Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine",

author = "Roger Chou and Jane Ballantyne and Anna Lembke",

note = "Funding Information: The authors thank the Oregon Pain Guidance Working Group (Jane Ballantyne, Roger Chou, Paul Coelho, Ruben Halperin, Andrew Kolodny, Anna Lembke, Jim Shames, Mark Stephens, and David Tauben) for discussions about tapering and for reviewing a draft of this article. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2019",

month = sep,

day = "17",

doi = "10.7326/M19-1488",

language = "English (US)",

volume = "171",

pages = "427--429",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "6",

}

TY - JOUR

T1 - Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine

AU - Chou, Roger

AU - Ballantyne, Jane

AU - Lembke, Anna

N1 - Funding Information: The authors thank the Oregon Pain Guidance Working Group (Jane Ballantyne, Roger Chou, Paul Coelho, Ruben Halperin, Andrew Kolodny, Anna Lembke, Jim Shames, Mark Stephens, and David Tauben) for discussions about tapering and for reviewing a draft of this article. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2019/9/17

Y1 - 2019/9/17

UR - http://www.scopus.com/inward/record.url?scp=85072509967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072509967&partnerID=8YFLogxK

U2 - 10.7326/M19-1488

DO - 10.7326/M19-1488

M3 - Comment/debate

C2 - 31450240

AN - SCOPUS:85072509967

SN - 0003-4819

VL - 171

SP - 427

EP - 429

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 6

ER -

Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this